EGFR inhibitor
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EGFR inhibitor, covering 2026-03-27 to 2026-03-27. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant PD-1 Inhibitor and EGFR Inhibitor in Locally Advanced Cutaneous Squamous Cell Carcinoma [Phase 2]